SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-051316
Filing Date
2020-04-27
Accepted
2020-04-27 08:13:57
Documents
15
Period of Report
2020-04-27
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8K tm2016900-1_8k.htm   iXBRL 8-K 40622
2 EXHIBIT 99.1 tm2016900d1_ex99-1.htm EX-99.1 45690
7 GRAPHIC tm2016900d1_ex99-1img001.jpg GRAPHIC 6657
  Complete submission text file 0001104659-20-051316.txt   356445

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA abbv-20200427.xsd EX-101.SCH 4481
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abbv-20200427_def.xml EX-101.DEF 30228
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE abbv-20200427_lab.xml EX-101.LAB 41943
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abbv-20200427_pre.xml EX-101.PRE 28431
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2016900-1_8k_htm.xml XML 9939
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

IRS No.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35565 | Film No.: 20817305
SIC: 2834 Pharmaceutical Preparations